Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
2.000
-0.080 (-3.85%)
At close: Nov 19, 2026, 4:00 PM EST
2.040
+0.040 (2.00%)
After-hours: Nov 19, 2026, 7:30 PM EST
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $109.62 million as of November 19, 2026. It is the 23,849th most valuable company in the world and the 3,908th biggest in the United States. Its market cap has decreased by 92.06% in one year.
Market Cap
109.62M
Enterprise Value
-96.95M
1-Year Change
-92.06%
Global Rank
Country Rank
#3,908 United States
Category
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has decreased from $393.35M to $109.62M, a decrease of -72.13%. That is a compound annual growth rate of -45.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 109.62M | -92.53% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 127.48M |
| enGene Therapeutics | 126.66M |
| NeOnc Technologies Holdings | 126.08M |
| PolyPid | 124.92M |
| Spruce Biosciences | 121.43M |
| LENZ Therapeutics | 120.03M |
| Compass Therapeutics | 119.13M |
| Codexis | 116.17M |